Tirzepatide (Mounjaro®) and other GLP1 medicines e.g. Semaglutide (Ozepmic®, Wegovy®, Rybelsus®) for weight loss
Currently we only prescribe Mounjaro® and other GLP1 medicine for people with Type 2 Diabetes. From 23/06/2025 some other people should be able to access this medication 92 the NHS but this roll-out is going to be delayed slightly.
At the moment, the criteria for NHS supply are quite strict, to allow those at highest risk to access these medicines first. This includes people already on the waiting list for bariatric surgery who are now eligible for these injections.
The current eligibility criteria for the highest risk people who will be able to access these injections via the NHS first, are those with a BMI of 40 or over plus 4 out of the following 5 medical issues:
- Dyslipidaemia (abnormal fat levels in the blood)
- Hypertension (high blood pressure)
- Obstructive Sleep Apnoea (when your breathing stops and starts while you sleep)
- Cardiovascular Disease (heart and blood vessel disease)
- Type 2 Diabetes
Each year the criteria may change slightly making more people eligible.
For more information on this, and other support available to help you in your weight loss journey go to https://www.hantsiow.icb.nhs.uk/weight-loss-support
How to use the Mounjaro Kwikpen
We would recommend watching the video below to see how to use the Mounjaro Kwikpen device. Please remember the following key points:
- Keep in the fridge until the Kwikpen is in use
- Once in use it can then be kept at 2-30 degrees C° for up to 30 days
- Do an “air shot” to prime the needle before each dose
- Count to 5 before removing the needle after a dose has been given
- Each pen contains four doses
Video demonstration
How to use Mounjaro injection UK version Kwikpen (Mounjaro injection instructions on a real patient)
